Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Date:8/6/2013

ese forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.AVANIR PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED BALANCE SHEETSJune 30,September 30,20132012(unaudited)(audited)ASSETSCurrent assets:Cash and cash equivalents

$
55,021,932$
9,778,406Restricted cash and cash equivalents

765,268652,913Trade receivables, net

12,137,6037,231,759Inventories, net

599,666415,475Prepaid expenses and other current assets

1,870,5132,434,590Restricted short-term investment

-401,550Total current assets

70,394,98280,914,693Restricted long-term investments

1,303,9381,302,136Property and equipment, net

1,614,0231,808,594Non-current inventories, net

849,266908,364Other assets

587,5281,078,009TOTAL ASSETS$
74,749,737$
86,011,796LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable, accrued expenses and other liabilities

$
20,000,566$
5,598,666Current portion of note payble

5,088,8072,162,263Current portion of deferred royalty revenues

1,960,1122,557,464Total current liabilities

27,049,48520,318,393Accrued expenses and other liabilities, net of current portion

1,256,446666,179Note Payable

24,174,40726,698,263Deferred royalty revenues, net of current portion

-1,491,854Total liabilities

52,480,33849,174,689Total stockholders' equity

22,269,39936,837,107TOTAL LIABILITIES AND STOCKHOLDERS'  EQUITY$
74,749,737$
86,011,796AVANIR PHARMACEUTICALS, INC.CONDENSED STATEMENT OF OPERATIONSThree Months Ended June 30,Nine Months Ended June 30,2013201220132012REVENUESNet product sales

$<
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Avanir Pharmaceuticals to Participate in Two Conferences in August
2. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
4. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
5. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
6. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
7. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
8. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
9. AVANIR Pharmaceuticals To paticipate in two conferences in March
10. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
11. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, ... EURONEXT: SAN) and the life sciences team at Google ... and outcomes for people with type 1 and type ... and devices with Google,s expertise in analytics, miniaturized electronics ... how to improve diabetes care by developing new tools ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
(Date:8/31/2015)... ... August 31, 2015 , ... The 2015 New York ... and family members, medical professionals, and researchers, covering a variety of topics related ... a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial ...
(Date:8/31/2015)... ... ... The Bay Pines VA Healthcare System (VAHCS) remains focused on ... doctors and nurses and expanding existing facilities and services. Spine surgery will soon ... Jabre was selected to lead and grow the Bay Pines VAHCS’s new spine surgery ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Surgery Program at Monmouth, was one of the first doctors in the area ... of this new approach have been impressive: faster recovery, decreased immediate and long-term ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Dr. Stewart ... may be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose ... common cause of visual impairment among children, affecting approximately 2 to 3 out of ...
(Date:8/31/2015)... ... August 31, 2015 , ... The dental implant and prosthetic market in the ... Implant Dentistry. (See Press Room ) More than 30 million Americans are missing ... the increasing demand for dental implants, the National Association of Dental Laboratories (NADL) created ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... Taiwan researchers said Thursday they have successfully tested 10 ... while prolonging patients' survival time with limited side ... led by Dr. Wong Chi-huey, president of Taiwan's highest ... in the structure and function of sugars. ...
... all financial aid to Amnesty International and called on ... accusing it of promoting abortion. "No more Catholic ... said a statement from the Vatican's Pontifical Council for ... Renato Martino, said the "suspension of all financing of ...
... concept catching up fast in the West. ,With the ... phones with hundreds of names and numbers stored in its ... these numbers belong to the near and dear. ,In ... had a heart attack and the physicians attending on the injured ...
... for Allergy & Immunology (LIAI) made an important finding, ... for treating autoimmune and inflammatory diseases such as ... studies, conducted in laboratory mice, demonstrated the role of ... broken down in the body, in regulating inflammation. ...
... Melbourne's Yarra River, posing serious threat to wildlife in the ... with the water until the slick - from the Chandler ... ,The Environment Protection Agency (EPA) is investigating the source ... but was not discovered until Tuesday by a kayaker using ...
... University of Illinois at Chicago and Cornell University are ... patients who suffer from Neurodegenerative diseases or stroke . ... events take place that lead to the death of ... called histone deacetylases can modulate gene expression, and in ...
Cached Medicine News:Health News:Taiwan Researchers Claim Cancer Therapy Alternative 2Health News:Catholics Should Halt Amnesty Support Over Abortion Issue: Vatican 2Health News:Look Out for ICE in Emergency Situations 2Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2Health News:Australia Battles Oil Slick on Yarra River 2Health News:Researchers Developing New Therapy to Re-activate Silenced Genes 2
LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
... New REFRESH LIQUIGEL® Lubricant Eye Drops ... with the convenience of a liquid ... protection. Its extra-strength CMC formula provides ... comfort. And with the PURITE® preservative, ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
Medicine Products: